Anemia
Advertisement
A team analyzed sotagliflozin's effects on hemoglobin in patients with stage 3-4 CKD and type 2 diabetes.
Before performing allogeneic HSCT in AA patients, clinicians should measure ANC as a prognostic factor.
Ajay K. Singh discussed his findings on daprodustat dosing and utilization of finerenone.
Researchers examined the roles of hyperuricemia and anemia in all-cause mortality with chronic kidney disease (CKD).
The ERA reviewed phase 3 trials to clarify the mechanism behind HIF-PHi and their role in managing CKD-related anemia.
The FDA approved Vafseo (vadadustat) to treat anemia due to chronic kidney disease (CKD) in adults on dialysis.
SGLT2 inhibitors have benefits for anemia risk but their effectiveness among patients with T2D and CKD stage 1-3 was unclear.
HSCT from a haploidentical donor and PTCy improved neutrophil and platelet engraftment compared with UCBT in aplastic anemia.
Anemia patients with nonvalvular atrial fibrillation have a higher risk of dying, a study finds.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.